Redapt 71354219
Redapt 71354219 is a sleeve femoral/tibial extension (FDA Class II; FDA product code MEH) made by Smith & Nephew, Inc., cleared under FDA 510(k) K211176 on 1 Jul 2022 (1 earlier submission) and listed in FDA GUDID since 30 Aug 2015 (UDI-DI 00885556254189), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
1 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k) | NumberK211176 | Date1 Jul 2022 | StatusActive |
| United States | GUDID listing | Number00885556254189 | Date30 Aug 2015 | StatusListed |
Official records
- AccessGUDID record 00885556254189
- FDA 510(k) database K211176
- FDA 510(k) database K100481
From the FDA record
- Device description
- REDAPT MODULAR SLEEVE 18-19 EXTRA SMALL GRIT-BLASTED FINISH
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied sterile
Across registries
- FDA 510(k) K211176 decided 1 Jul 2022 Active
- FDA GUDID UDI-DI 00885556254189 listed 30 Aug 2015 Listed
Recalls
-
- Ongoing Z-0326-2025
The Bipolar assembly contains an oversized Retainer Ring.
Timeline
- Cleared FDA 510(k) K100481
- Listed FDA GUDID 00885556254189
- Cleared FDA 510(k) K211176
- Recall initiated FDA recalls Z-0326-2025
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Redapt
- Generic name
- Sleeve femoral/tibial extension, uncoated
- Model / Ref / Catalog
- 71354219
- Description
- REDAPT MODULAR SLEEVE 18-19 EXTRA SMALL GRIT-BLASTED FINISH
- Primary DI / UDI-DI
- 00885556254189
- FDA product code
- MEH
- GMDN term
- Sleeve femoral/tibial extension, uncoated
- Device class
- Class II
- Regulation number
- 888.3353
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under Sleeve femoral/tibial extension, uncoated.